Search

everythinglearnresearchcommunity

for

Search:↓

Rosemary essential oil spray can effectively increase hair density in alopecia treatment.

Cyclophosphamide is preferred for severe cases in pediatric rheumatology and nephrology despite its side effects.

The treatment improved hair thickness, shine, and reduced hair loss effectively.

Lipid peroxidation worsens skin diseases but may help treat cancer.

Ritlecitinib is generally safe for adolescents with alopecia areata over 5 years.

Ritlecitinib 50 mg effectively promotes and sustains hair regrowth in alopecia areata patients.

Ritlecitinib improves hair regrowth satisfaction in alopecia areata patients.

Ritlecitinib is effective long-term for treating alopecia areata in teens.

Ritlecitinib may be more effective for severe alopecia areata than conventional treatments.

Combining antihistamines with topical treatment improves hair regrowth in alopecia areata.

Stress may affect hair growth by influencing hair follicle development and could contribute to hair loss.

Men have more tryptophan in their hair than women, and it increases with age and is higher in darker and grey or white hair.

BI 2536 had limited effectiveness against several advanced cancers and caused significant side effects.

The new clinical trial design is promising but needs real-world trials to test its effectiveness and possible enhancements.

The drug IPI-926 is safe at 160 mg daily and may help treat certain tumors, especially basal cell carcinoma.

Safusidenib erbumine shows promise as a treatment for certain brain tumors, but mild side effects like hair loss need attention.

The treatment showed high response rates and was well-tolerated, potentially extending patient survival.

MK-5108 is safe and shows potential against tumors, especially alone.

CT-707 is effective and safe for treating certain Chinese lung cancer patients.

The new chemotherapy combination for advanced lung cancer showed a 35.7% response rate but caused significant side effects.

ASLAN004 was safe and well-tolerated, supporting further development for treating certain diseases.

The drug showed promise in treating renal cell carcinoma with manageable side effects.

Neoadjuvant chemotherapy followed by surgery leads to fewer severe complications and better quality of life than immediate surgery in advanced ovarian cancer patients with high tumor load.

IGRT resulted in lower acute toxicity for stage III prostate cancer patients.

Baricitinib helped improve hair, eyebrow, and eyelash growth in alopecia areata patients.

Understanding specific symptoms in different cancer stages can improve personalized care and quality of life.

Aleglitazar and its major metabolite are safe enough to proceed to Phase 3 clinical trials.

Baricitinib was effective in regrowing eyebrow and eyelash hair in patients with severe alopecia areata.

The treatment combining docetaxel, cisplatin, and 5-FU is feasible and effective for advanced head and neck cancer.